Skip to main content
BioNote, Inc. logo

BioNote, Inc. — Investor Relations & Filings

Ticker · 377740 ISIN · KR7377740006 KO Manufacturing
Filings indexed 160 across all filing types
Latest filing 2022-12-27 Director's Dealing
Country KR South Korea
Listing KO 377740

About BioNote, Inc.

https://www.bionote.com/

BioNote, Inc. is a company specializing in in-vitro diagnostics for the animal health industry. It develops, manufactures, and distributes a range of veterinary diagnostic products, including rapid test kits, ELISA kits, point-of-care (POC) analyzers, and biomarker tests. The company's portfolio is based on its research and development of core biological components like antigens and antibodies. Its products are designed for the detection and diagnosis of animal diseases, providing veterinarians with tools for immunochemical and quantitative analysis in clinical settings.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to report insider holdings and transactions by directors or major shareholders. In the provided taxonomy, 'Director's Dealing' (DIRS) is the correct category for reports concerning personal share transactions or ownership status by company directors and executives.
2022-12-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory disclosure for insider shareholdings, which corresponds to the 'Director's Dealing' (DIRS) category in the provided schema.
2022-12-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and the Korea Exchange. This type of filing is specifically used for reporting insider holdings and changes in ownership by directors or major shareholders, which corresponds to the 'Director's Dealing' (DIRS) category in the provided schema.
2022-12-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and the Korea Exchange. This is a standard regulatory filing for insider shareholding disclosures, which falls under the 'Director's Dealing' category as it reports the share ownership status of an executive (Seong Ju-hwan) of Bionote Inc.
2022-12-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status of major shareholders (Cho Young-sik and special related parties) in Bionote Inc. following its listing on the KOSPI market. This document type is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-12-27 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. This document details the final results of a public offering, including subscription and allocation data, underwriting information, and the final number of shares issued. It is a standard regulatory filing required after a capital raise or IPO. Since it is a formal report of issuance results rather than an announcement of a report or a general regulatory notice, it falls under the 'Share Issue/Capital Change' category.
2022-12-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.